Clinical Trial Update: Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma [Phase 1]

View source ↗

Summary

The Phase 1 trial evaluating concurrent pemetrexed/cisplatin with pleural intensity-modulated radiation therapy for unresectable malignant pleural mesothelioma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Malignant Pleural Mesothelioma | Phase 1 | Status: WITHDRAWN